- Home
- EYEN vs AQB Comparison
EYEN vs AQB Comparison
Compare EYEN & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- AQB
- Stock Information
- Founded
- EYEN 2014
- AQB 1991
- Country
- EYEN United States
- AQB United States
- Employees
- EYEN N/A
- AQB N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- AQB
- Sector
- EYEN Health Care
- AQB
- Exchange
- EYEN Nasdaq
- AQB Nasdaq
- Market Cap
- EYEN 2.9M
- AQB 2.9M
- IPO Year
- EYEN 2018
- AQB N/A
- Fundamental
- Price
- EYEN $4.88
- AQB $0.79
- Analyst Decision
- EYEN Hold
- AQB
- Analyst Count
- EYEN 4
- AQB 0
- Target Price
- EYEN $2.00
- AQB N/A
- AVG Volume (30 Days)
- EYEN 7.1M
- AQB 152.9K
- Earning Date
- EYEN 05-19-2025
- AQB 08-05-2025
- Dividend Yield
- EYEN N/A
- AQB N/A
- EPS Growth
- EYEN N/A
- AQB N/A
- EPS
- EYEN N/A
- AQB N/A
- Revenue
- EYEN $67,063.00
- AQB N/A
- Revenue This Year
- EYEN $7,680.45
- AQB N/A
- Revenue Next Year
- EYEN $315.38
- AQB N/A
- P/E Ratio
- EYEN N/A
- AQB N/A
- Revenue Growth
- EYEN 663.82
- AQB N/A
- 52 Week Low
- EYEN $0.85
- AQB $0.47
- 52 Week High
- EYEN $124.80
- AQB $1.94
- Technical
- Relative Strength Index (RSI)
- EYEN 86.35
- AQB 50.51
- Support Level
- EYEN $1.62
- AQB $0.78
- Resistance Level
- EYEN $2.30
- AQB $0.95
- Average True Range (ATR)
- EYEN 0.53
- AQB 0.08
- MACD
- EYEN 0.27
- AQB -0.01
- Stochastic Oscillator
- EYEN 79.17
- AQB 22.11
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.